Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  DexCom, Inc.    DXCM   US2521311074

DEXCOM, INC. (DXCM)

6
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/19/2014 11/20/2014 11/21/2014 11/24/2014 11/25/2014 Date
50.48(c) 50.85(c) 50.37(c) 51.18(c) 50.71(c) Last
561 853 378 577 738 976 804 929 643 029 Volume
-2.15% +0.73% -0.94% +1.61% -0.92% Change
More quotes
Company
DexCom, Inc. is a medical device manufacturing company.The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic... 
Surperformance© rating of DexCom, Inc.
Trading Rating : Investor Rating :
More about the company
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 244 M
EBIT 2014 -26,3 M
Net income 2014 -26,6 M
Debt 2014 -
Yield 2014 -
Sales 2015 339 M
EBIT 2015 0,59 M
Net income 2015 0,12 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 16,1x
Capi. / Sales 2015 11,6x
Capitalization 3 918 M
More Financials
Latest news on DEXCOM, INC.
1d ago DEXCOM : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ..
1d ago DEXCOM : Change in Directors or Principal Officers (form 8-K/A)
1d ago DEXCOM : to Present at 26th Annual Piper Jaffray Healthcare Conference
7d ago DEXCOM : Change in Directors or Principal Officers, Other Events (form 8-K)
7d ago DEXCOM : Announces Appointment of Mark G. Foletta as Board Member
11/17 DEXCOM : Assigned Patent
11/09 DEXCOM : to Present at Upcoming Conferences
11/06 DEXCOM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
11/06 DEXCOM : misses 3Q profit forecasts
11/06 DEXCOM : Results of Operations and Financial Condition, Financial Statements and..
11/06 DEXCOM : Reports Third Quarter 2014 Financial Results
11/06 DEXCOM : FDA Approves Dexcom Software with Artificial Pancreas Algorithm
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF